Daclatasvir hydrochloride is a hydrochloride obtained by combining daclatasvir with two molar equivalents of hydrochloric acid. It is a potent inhibitor of nonstructural protein 5A and is used for treatment of hepatitis C. Its therapeutic use is listed as anti-infectives. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Daklinza and Daclatasvir hydrochloride. Its PubChem CID is 25154713.
Daclatasvir dihydrochloride
| CAS No | 1009119-65-6 |
|---|---|
| Molecular Formula | C40H52Cl2N8O6 |
| Molecular Weight | 811.8 g/mol |
| Synonyms | methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;dihydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Daclatasvir hydrochloride is a hydrochloride obtained by combining daclatasvir with two molar equivalents of hydrochloric acid. It is a potent inhibitor of nonstructural protein 5A and is used for treatment of hepatitis C.
The listed CAS number is 1009119-65-6.
The listed molecular formula is C40H52Cl2N8O6.
The listed molecular weight is 811.8 g/mol.
methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate;dihydrochloride.
The source lists Daklinza and Daclatasvir hydrochloride.